Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | GPR109B |
Upstream (Parents) |
---|
(<<) ADCY3 → GPR109B |
(<<) ARHGEF4 → GPR109B |
(<<) CAV1 → GPR109B |
(<<) CRYAB → GPR109B |
(<<) DHRS9 → GPR109B |
(<<) EMP1 → GPR109B |
(<<) FZD4 → GPR109B |
(<<) G0S2 → GPR109B |
(<<) GNAI1 → GPR109B |
(<<) GNG10 → GPR109B |
(<<) HDAC4 → GPR109B |
(<<) HS2ST1 → GPR109B |
(<<) HSD11B1 → GPR109B |
(<<) PDE2A → GPR109B |
(<<) PDK2 → GPR109B |
(<<) PRKCB → GPR109B |
(<<) RHOT2 → GPR109B |
(<<) SOX17 → GPR109B |
(<<) TRAF2 → GPR109B |
Downstream (Children) |
---|
GPR109B → CACNA1I (>>) |
GPR109B → E2F2 (>>) |
GPR109B → FOXC2 (>>) |
GPR109B → GDNF (>>) |
GPR109B → HYAL1 (>>) |
GPR109B → KLK5 (>>) |
GPR109B → LARP6 (>>) |
GPR109B → PNPLA3 (>>) |
GPR109B → RHBDL1 (>>) |
GPR109B → RPS6KB2 (>>) |
GPR109B → SLC6A14 (>>) |
GPR109B → TRAF6 (>>) |